{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:13:05Z","timestamp":1789456385361,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12876-016-0441-4","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T04:10:53Z","timestamp":1456287053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A case report of sevelamer-associated recto-sigmoid ulcers"],"prefix":"10.1186","volume":"16","author":[{"given":"Christina","family":"Tieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger K.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M. Wong Kee","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shounak","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos A.","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie C.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,24]]},"reference":[{"issue":"1","key":"441_CR1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/kisup.2012.66","volume":"3","author":"Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","year":"2013","unstructured":"Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Chapter 3: Management of progression and complications of CKD. Kidney Int Suppl (2011). 2013;3(1):73\u201390.","journal-title":"Kidney Int Suppl (2011)"},{"issue":"3","key":"441_CR2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.ASN.0000113243.24155.2F","volume":"15","author":"LA Stevens","year":"2004","unstructured":"Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A. Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol. 2004;15(3):770\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"441_CR3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","volume":"16","author":"B Kestenbaum","year":"2005","unstructured":"Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005;16(2):520\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"441_CR4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","volume":"67","author":"EW Young","year":"2005","unstructured":"Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2005;67(3):1179\u201387.","journal-title":"Kidney Int"},{"key":"441_CR5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/IJNRD.S41626","volume":"7","author":"S Ossareh","year":"2014","unstructured":"Ossareh S. Clinical and economic aspects of sevelamer therapy in end-stage renal disease patients. Int J Nephrol Renovasc Dis. 2014;7:161\u20138.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"9900","key":"441_CR6","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","volume":"382","author":"SA Jamal","year":"2013","unstructured":"Jamal SA, Vandermeer B, Raggi P, Mendelssohn DC, Chatterley T, Dorgan M, et al. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet. 2013;382(9900):1268\u201377.","journal-title":"Lancet"},{"issue":"1","key":"441_CR7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0272-6386(97)90009-3","volume":"29","author":"GM Chertow","year":"1997","unstructured":"Chertow GM, Burke SK, Lazarus JM, Stenzel KH, Wombolt D, Goldberg D, et al. Poly [allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Am J Kidney Dis. 1997;29(1):66\u201371.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"441_CR8","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/ndt\/12.8.1640","volume":"12","author":"SK Burke","year":"1997","unstructured":"Burke SK, Slatopolsky EA, Goldberg DI. RenaGel, a novel calcium- and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteers. Nephrol Dial Transplant. 1997;12(8):1640\u20134.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"441_CR9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","volume":"62","author":"GM Chertow","year":"2002","unstructured":"Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62(1):245\u201352.","journal-title":"Kidney Int"},{"key":"441_CR10","volume-title":"Asian Wall Street Journal","author":"L Johannes","year":"2001","unstructured":"Johannes L, Armstrong D. Genzyme\u2019s Renagel Push Draws Heavy Criticism --- Company Says Drug Is Safer for Dialysis Patients. In: Asian Wall Street Journal. Victoria, Hong Kong: Dow Jones & Company Inc; 2001."},{"key":"441_CR11","unstructured":"RENVELA\u00ae Prescribing Information [ http:\/\/products.sanofi.us\/Renvela\/Renvela.html ]. Accessed 12\/31\/2015."},{"key":"441_CR12","unstructured":"MedWatch: The FDA Safety Information and Adverse Event Reporting Program [ http:\/\/www.fda.gov\/Safety\/MedWatch\/ ]. Accessed 12\/31\/2015."},{"key":"441_CR13","unstructured":"Product Information: RENVELA - (sevelamer carbonate) tablet, film coated for oral use [ http:\/\/dailymed.nlm.nih.gov\/dailymed\/archives\/fdaDrugInfo.cfm?archiveid=10490 ]. Accessed 12\/31\/2015."},{"issue":"16","key":"441_CR14","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.3748\/wjg.14.2615","volume":"14","author":"P Madan","year":"2008","unstructured":"Madan P, Bhayana S, Chandra P, Hughes JI. Lower gastrointestinal bleeding: association with Sevelamer use. World J Gastroenterol. 2008;14(16):2615\u20136.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"441_CR15","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3182999d8d","volume":"37","author":"BJ Swanson","year":"2013","unstructured":"Swanson BJ, Limketkai BN, Liu TC, Montgomery E, Nazari K, Park JY, et al. Sevelamer crystals in the gastrointestinal tract (GIT): a new entity associated with mucosal injury. Am J Surg Pathol. 2013;37(11):1686\u201393.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"441_CR16","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.2215\/CJN.04970512","volume":"7","author":"AW Williams","year":"2012","unstructured":"Williams AW, Dwyer AC, Eddy AA, Fink JC, Jaber BL, Linas SL, et al. Critical and honest conversations: the evidence behind the \u201cChoosing Wisely\u201d campaign recommendations by the American Society of Nephrology. Clin J Am Soc Nephrol. 2012;7(10):1664\u201372.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-016-0441-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T02:40:53Z","timestamp":1498272053000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-230X\/16\/20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,24]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["441"],"URL":"https:\/\/doi.org\/10.1186\/s12876-016-0441-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,24]]},"article-number":"20"}}